This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025 | In-Person + Digital
Manchester Grand Hyatt San DiegoSan Diego, CA

Hiroaki Suga, PhD
Professor of Chemistry, School of Science at University of Tokyo, Japan
Speaker

Profile

Hiroaki Suga is a Professor at the Department of Chemistry, Graduate School of Science, University of Tokyo. His research interests are in the field of bioorganic chemistry, chemical biology and biotechnology related to RNA, translation, and peptides. His lab utilizes organic chemistry techniques in combination with biology to tackle yet unresolved questions and develop novel technologies with broad applicability, which can be extended to drug discovery. He is the co-founder of PeptiDream and MiraBiologics, companies providing novel modalities for drug discovery and development.

Prof. Suga received his Bachelor of Engineering (1986) and Master of Engineering (1989) from Okayama University, Ph.D. in Chemistry (1994) from MIT, and was a post-doctoral fellow at the Massachusetts General Hospital. Suga began his independent career at New York State University at Buffalo (1997-2003). In 2003 he moved to the Research Center for Advanced Science and Technology at the University of Tokyo. Since 2010 Suga has been a full Professor in the department of chemistry at the University of Tokyo.